Groups | Complementary Medicine | Adverse events | Bradycardiaa |
---|
Group D1 | 3 (15%) | 0 | 0 |
Group D2 | 0 | 0 | 1 (5%) |
Group D3 | 1 (5%) | 3 (15%) | 3 (15%) |
Group D4 | 0 | 1 (5%) | 2 (10%) |
Group D5 | 0 | 1 (5%) | 2 (10%) |
- There were no statistically significant differences (P > 0.05) among the groups
- aBradycardia was defined as HR decrease of ≥30% during the 5-min observation period postdexmedetomidine bolus, compared to predexmedetomidine bolus baseline values